Most people on dolutegravir resuppress viral load after a detectable result
Dolutegravir resistance very rare after a switch - even with detectable HIV
Uganda achieves rapid scale-up of cervical screening for women living with HIV
Much lower HIV knowledge and access to testing for people with disabilities globally
Once-weekly combination of islatravir and lenacapavir safe and effective in 48-week study
23% of people with HIV in the UK have depression or anxiety, but rates are much higher in some groups
HIV status does not affect liver transplant outcomes, 15-year Spanish study finds
Integrase inhibitor resistance after treatment failure more common in treatment-experienced people
One in nine gay and bisexual men using PrEP in Europe gets it through informal channels
Statins and lifestyle changes recommended for more people living with HIV by European experts
Novel antibody-based regimen keeps HIV at bay for six months
Higher dose chosen for ongoing study
Six-monthly injectable PrEP is 89% more effective than oral PrEP in gay and bisexual men and trans people
The long-acting HIV treatment era is just beginning
Second woman possibly cured of HIV
Public Statement: Transition of Aidsmap and NAM Publications' Assets to Terrence Higgins Trust and National AIDS Trust
Accessible HIV science is vital in an age of disinformation
Terrence Higgins Trust is exploring a future for leading HIV website aidsmap